Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trialCaicun Zhou, Jianjun Zou, Lizhu Lin et al.|The Lancet Respiratory Medicine|2020Cited by 504
Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian womenZhaoming Wang, Wu‐Chou Su, Wei Jie Seow et al.|Human Molecular Genetics|2016Cited by 58